Q32 Bio Stock Forecast

QTTB's stock price has decreased by -91.74% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 8 analysts that cover Q32 Bio stock have a consensus rating of "Hold" and an average price target of $24, which forecasts a 1404.7% increase in the stock price over the next year. The lowest target is $3 and the highest is $95.

Price Target: $24 (+1404.7%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$24	$15	$95
Change	+88.09%	+1404.7%	+840.44%	+5856.1%

* Price targets were last updated on Mar 12, 2025.

Analyst Ratings

The average analyst rating for Q32 Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	0	0	0	0	0	0
Buy	5	3	3	3	3	3
Hold	3	5	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $16 → $15	Hold	Maintains	$16 → $15	+840.44%	Mar 12, 2025
Etzer Darout BMO Capital	BMO Capital	Buy → Hold Downgrades $22 → $3	Buy → Hold	Downgrades	$22 → $3	+88.09%	Feb 11, 2025
Christopher Raymond Piper Sandler	Piper Sandler	Buy → Hold Downgrades $20 → $4	Buy → Hold	Downgrades	$20 → $4	+150.78%	Feb 11, 2025
Etzer Darout BMO Capital	BMO Capital	Buy Maintains $64 → $22	Buy	Maintains	$64 → $22	+1,279.31%	Dec 12, 2024
Yatin Suneja Guggenheim	Guggenheim	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.38

from -6.58

EPS Next Year

-4.52

from -4.38

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	6.65M	-6.65M	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-5.81	-6.09	-153.96	-6.58	-4.38	-4.52	-6.60
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	6	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-4.48	-3.82	-6.06
Avg	-4.38	-4.52	-6.60
Low	-4.23	-5.12	-7.04

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.